@SmallCapKing2@fin_pollution Im new to risk arb but i imagine its not common practice to publicly negotiate a counteroffer so the passage of time infers greater probability of consummation. My .02 at a discount for .00))
@sv_techie@LogicalThesis I reviewed ER transcript. Didnt seem like a bad ER. Am i missing something?? Seems like offerfit will bring synergies. And really nothing to complain about in terms of growth… still think its got room to run up and potentially get a BO offer…
$xpev anyone got thoughts on xpev?? Last 2 weeks straight decline and i see some heavy $19puts for july…long term i think its a winner but maybe losing steam??
@no__bs__ any thoughts as to why it is -5% post ER? EPS beat, revenue came in little light. didn't hear the call but on the surface things look bright....